An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations.

Background: Aside from the pandemic's negative health effects, the world was confronted with public confusion since proper communication and favorable decisions became an ongoing challenge. As a result, the public's perceptions were influenced by what they knew, the many sources of COVID-19 information, and how they interpreted it. With cancer patients continuing to oppose COVID-19 vaccines, we sought to investigate the COVID-19 pandemic and vaccine sources of this information in adult cancer patients, which either helped or prevented them from taking the vaccine.

Science-based health innovation in Uganda: creative strategies for applying research to development.

Background: Uganda has a long history of health research, but still faces critical health problems. It has made a number of recent moves towards building science and technology capacity which could have an impact on local health, if innovation can be fostered and harnessed.

Methods: Qualitative case study research methodology was used.

Science-based health innovation in Ghana: health entrepreneurs point the way to a new development path.

Background: Science, technology and innovation have long played a role in Ghana's vision for development, including in improving its health outcomes. However, so far little research has been conducted on Ghana's capacity for health innovation to address local diseases. This research aims to fill that gap, mapping out the key actors involved, highlighting examples of indigenous innovation, setting out the challenges ahead and outlining recommendations for strengthening Ghana's health innovation system.

Science-based health innovation in sub-Saharan Africa.

In recent years emerging markets such as India, China, and Brazil have developed appropriate business models and lower-cost technological innovations to address health challenges locally and internationally. But it is not well understood what capabilities African countries, with their high disease burden, have in science-based health innovation.This gap in knowledge is addressed by this series in BMC International Health and Human Rights.

Small but tenacious: South Africa's health biotech sector.

Despite a challenging business environment, entrepreneurial health biotech companies in South Africa are finding ways to succeed.

Chinese health biotech and the billion-patient market.

Unlabelled: Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits.

Supplementary Information: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users.